News
26 September 2024
Synergy Spine Solutions Ltd has announced the successful completion of patient enrollment in its U.S. 2-Level Investigational Device Exemption (IDE) clinical trial, aimed at assessing the safety and effectiveness
Read more...Medtronic plc, a leader in healthcare technology, will present its latest innovations in deep brain stimulation (DBS) at the International Congress of Parkinson?s Disease and Movement Disorders?
Read more...25 September 2024
Phy Health, a technology company specializing in data-driven assessments and treatment plans for musculoskeletal health, has formed a partnership with Extension Health, a leading longevity clinic in New York City
Read more...25 September 2024
Cybernet has launched a groundbreaking series of AI-enabled computers, featuring the latest processors and GPUs from Intel? and NVIDIA?. The new CyberMed Ai3 medical AI box PC
Read more...24 September 2024
Merz Aesthetics has unveiled Ultherapy PRIME, a noninvasive, FDA-cleared treatment designed to provide personalized and long-lasting lifting results in a single session, with no recovery time required.
Read more...23 September 2024
The International Myeloma Foundation (IMF) has launched Myelo, an AI-powered chatbot designed to support myeloma patients, care partners, and healthcare professionals. This innovative tool offers
Read more...21 September 2024
XpertDox, a leader in AI-driven medical coding software, has partnered with Blue Fish Pediatrics, a premier pediatric care provider in Texas, to enhance the efficiency and accuracy of medical coding across its clinics.
Read more...20 September 2024
Burson, a global leader in communications focused on enhancing client reputations, has introduced Decipher Health, a new cognitive artificial intelligence (AI) tool designed to improve communication
Read more...20 September 2024
DeepLook Medical, specializing in visual enhancement technology for medical imaging, has successfully completed the initial closing of its Series A funding round, led by Xcellerant Ventures with support from OKG Capital.
Read more...19 September 2024
Vivos Therapeutics, known for its medical devices addressing sleep-related breathing disorders (SRBDs) like obstructive sleep apnea (OSA), has received FDA 510(k) clearance for its oral medical device
Read more...